Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France.

Journal Information

Full Title: Eur J Public Health

Abbreviation: Eur J Public Health

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest J.B.-H. and A.P. are employees and stakeholders of Sanofi. L.B., K.S., C.B. and J.R. received consultancy fees for the development of this study by Sanofi. Key pointsThe incidence of vaccine-preventable diseases continues to be high despite the availability of vaccines.A cost calculator was developed to assess the cost of illness of influenza, herpes zoster, and pneumococcal disease in France among older adults aged ≥65 years.Influenza is the leading cause of vaccine-preventable diseases and is associated with the highest economic burden among older adults.Increasing vaccine uptake could alleviate the substantial economic burden caused by influenza."

Evidence found in paper:

"Funding This study was funded by Sanofi."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025